Back to MA Mirae Asset Global Investments Co., Ltd.

ARWRARWR

Showing 9 of 30 quarters

Position history for MAMirae Asset Global Investments Co., Ltd.'s holdings in Arrowhead Pharmaceuticals, Inc.

Yes. Mirae Asset Global Investments holds 7,218 shares of ARWR (Arrowhead Pharmaceuticals), worth $472,418, as of its Q3 2026 13F filing. It increased the position by 918 shares (+14.6%) from Q2 2026. Mirae Asset Global Investments has held ARWR since Q2 2019, across 30 quarterly 13F filings.

Current Value

$472,418

Current Shares

7,218

Total Value Change

+$383,982

Total Shares Change

+2,722

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
7,218
+14.6%
$472,4180.0%$65.45
27
2026-Q2
Decreased
6,300
-13.8%
$513,5130.0%$81.51
0
2026-Q1
Increased
7,304
+10.7%
$457,9610.0%$62.70
27
2025-Q4
Increased
6,599
+23.5%
$438,1080.0%$66.39
29
2025-Q3
Increased
5,345
+0.2%
$184,3490.0%$34.49
23
2025-Q2
Increased
5,335
+29.5%
$84,2930.0%$15.80
27
2025-Q1
Decreased
4,121
-0.6%
$56,9520.0%$12.74
0
2024-Q4
Decreased
4,147
-7.8%
$78,6270.0%$18.80
0
2024-Q3
Increased
4,496
+21.3%
$88,4360.0%$19.37
26

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used